The Patent Finder

Novel Egfr Modulators and Uses Thereof

Acea Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,685,988Novel Egfr Modulators and Uses Thereof
In force
 · High confidence
UsedRemaining
Acea Therapeutics, Inc.In forceHigh confidence
US 9,586,965PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES
In force
 · Medium confidence
Acea Therapeutics, Inc.In forceMedium confidence
US 9,763,949Novel Egfr Modulators and Uses Thereof
In force
 · High confidence
Acea Therapeutics, Inc.In forceHigh confidence
US 10,449,196Novel Egfr Modulators and Uses Thereof
In force
 · Medium confidence
Acea Therapeutics, Inc.In forceMedium confidence
US 10,596,174Pyrrolopyrimidine Compounds as Inhibitors of Protein Kinases
In force
 · Medium confidence
Acea Therapeutics, Inc.In forceMedium confidence
US 9,034,885Novel Egfr Modulators and Uses Thereof
In force
 · Medium confidence
Acea Therapeutics, Inc.In forceMedium confidence
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Acea Biosciences, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited